Xconomy

FEBRUARY 7, 2019

Gossamer Bio, the San Diego-based biotech founded by former Receptos executives, has raised $276 million in its initial public offering, a total that puts it in a rare class among biotechs that have gone public in recent years. The amount raised surpassed expectations.

San Diego 99

San Diego Class Pricing Marketing 99

Xconomy

JULY 26, 2019

Yet Frenkel, a participant in the summer 2015 class at Y Combinator , an influential Silicon Valley accelerator program, raised $120,000 from investors by August that year. Early this year, she sold her company, This is L. , to Cincinnati, OH-based Procter & Gamble (NYSE: PG ).

Software Engineering 110

Software Engineering Class Startup Software 110

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. Entrepreneurs at work on first day of Canopy San Diego accelerator program.

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

OCTOBER 9, 2019

Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in information technology almost exclusively. That opening to biotech startups in 2014 was controversial at the time.

Incubator 108

Incubator Class Artificial Inteligence Startup 108

Xconomy

SEPTEMBER 28, 2018

XRC Labs, an accelerator program focused on e-commerce and retail startups, held a demo day for its latest class Thursday, featuring innovations in artificial intelligence, virtual reality, and other technologies. Consumers are changing faster than the retailers,” and that is resulting in shoppers bypassing traditional stores.

Artificial Inteligence 97

Artificial Inteligence Class Commerce Design 97

Xconomy

FEBRUARY 21, 2017

San Diego-based Cidara (NASDAQ: CDTX ) said in a statement on Tuesday it will now shift its resources to other compounds in its portfolio, including an intravenous form of the antifungal. Cidara’s drug, CD101, is part of a class of antifungal drugs called echinocandins that target the. this morning.

San Diego 58

San Diego Class News Resource 58

Xconomy

APRIL 17, 2017

San Diego-based TakeLessons set out nine years ago to create a Web-based platform that helped match music students with qualified instructors. TakeLessons also acquired Chicago-based Betterfly, which offered online vocational classes, DIY projects, and self-improvement courses like public speaking and personal life coaching.

Venture Capital 59

Venture Capital San Diego Santa Monica Coach 59

Xconomy

AUGUST 30, 2016

UC San Diego has named Todd Hylton, a veteran tech industry manager and expert in neural-based processing technology, as executive director of its new Contextual Robotics Institute. Hylton’s appointment comes less than two months after UC San Diego named Henrik Christensen as director of the robotics institute.

UCSD 49

UCSD San Diego Artificial Inteligence Research 49

Xconomy

APRIL 22, 2020

The start of a potentially big biomedical breakthrough is blooming within all of us. In every new (drug) class there’s always been people. Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more. Read more » Reprints | Share:

Class 138

Class Study Research Report 138

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. So far this year four privately held companies have made the transition to trading on the public markets.

Westlake Village 109

Westlake Village Class Research Capital 109

Xconomy

JULY 24, 2017

San Diego’s Effector Therapeutics, a five-year-old cancer drug developer, has raised $38.6 million in new venture capital funding. The Series C financing, led by Pfizer Venture Investments, brings total funding for Effector to about $150 million, CEO Steve Worland said late Monday.

Class 59

Class Venture Capital Funding Invest 59

Tech Zulu Event

JUNE 28, 2012

The first-ever Silicon Beach Fest attracted more than 2,000 attendees from LA, San Francisco, San Diego, Santa Barbara, New York, Toronto, and London to celebrate LA startups and entertainment with panels, parties, pitch fests, hackathon, and beach games: volleyball, basketball and surfing lessons in Santa Monica and Venice on June 21-23, 2012.

Hollywood 67

Hollywood Technical Review Startup Rustic Canyon 67

Xconomy

APRIL 4, 2018

The advent of big fundraising rounds for startup chip innovators—a class shunned by most venture capital firms only a few years ago—seems to mark a turnaround in recent VC attitudes about semiconductor investments.

Artificial Inteligence 69

Artificial Inteligence Venture Capital Class Capital 69

Xconomy

SEPTEMBER 18, 2020

Gilead Sciences CEO Daniel O’Day has spoken openly about acquisitions as a way to build up the company’s drug pipeline. This drug class has seen a lift in recent years. This week, it made its biggest buy yet. Some of those analysts think Gilead might have overpaid but the company says there were competing offers. The FDA has approved.

Class 67

Class Acquisition LAVA San Diego 67

Xconomy

SEPTEMBER 19, 2016

Think “innovation” and you might picture some scrappy entrepreneurs toiling away in a kitchen or garage, hoping the landlord doesn’t notice what they’re up to. Alexandria has put up buildings in virtually every key life science cluster in the U.S., Lately, Alexandria is aggressively expanding its reach.

Venture Capital 40

Venture Capital Startup San Diego Class 40

Xconomy

OCTOBER 19, 2018

The second centered around a group of pricey new migraine drugs: The nation’s largest drug-pricing middleman used a familiar muscle-flexing tactic to grab some discounts, and kicked one drug in the class to the curb as a result. Read more » Reprints | Share:

Pricing 74

Pricing Class San Diego Venture Capital 74

Xconomy

MAY 24, 2018

Bloom Science , a biotech founded to advance a new class of microbe-based therapeutics for neurological disorders, is making its debut today with the publication of research that suggests certain bacteria in the gut could be used to manage epileptic seizures.

Journal 76

Journal UCLA Class Research 76

Xconomy

JUNE 22, 2017

Repare can thank the early success of a class of drug called PARP inhibitors, which block an enzyme that cancer cells with. The newest company aiming to fight cancer with synthetic lethality is Repare Therapeutics, which today announced a $68 M Series A funding after more than 18 months in stealth.

Class 77

Class Ideas Funding San Diego 77

Xconomy

OCTOBER 25, 2016

Notwithstanding this robust pace, the “funding gap” persists (see above), strongly suggesting that non-VCs continue to invest aggressively in startups. Editor’s note: A longer version of this post originally appeared on Greeley’s blog, “On the Flying Bridge.” ]. Reprints | Share: UNDERWRITERS AND PARTNERS.

Venture Capital 40

Venture Capital Capital Activity Invest 40

Xconomy

AUGUST 19, 2016

Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

OCTOBER 21, 2016

. —Xconomy reported Monday that Tom Daniel, Celgene’s (NASDAQ: CELG ) former president of research and early development, left the Summit, NJ, company over the summer to start Catalysis Advisors in San Diego. THE REGULATORS’ THUMBS GO UP AND DOWN. His slides are here.

Research 40

Research San Diego Report Slides 40

SoCal Delicious

OCTOBER 8, 2012

Developments Blog. Tech entrepreneurs and executives from Silicon Valley are moving south and buying up luxury homes in the Los Angeles area. He uses his former home, a just-under 900-square-foot beach bungalow two blocks away, to house Facebook employees visiting from up north. Loading… Real Estate. » More.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

MAY 2, 2017

Donald Trump spent his 100th day in office in ways that would appeal to his working class base—holding a campaign-style rally in Harrisburg, PA, where he confirmed his campaign commitment to controlling immigration.

Class 52

Class Activity Technology Artificial Inteligence 52

Xconomy

SEPTEMBER 23, 2016

A Bay Area virtual reality startup is about to add new dimensions to the sync-watching experience for viewers of NBC News’s coverage of events leading up to the presidential election on Nov 8. The use of biological metrics and neuroscience in marketing is starting to expand to political research and campaign strategy-making.

Technical Review 40

Technical Review News Social Media Startup 40

Xconomy

JULY 26, 2016

It’s when you start to pick apart the specific innovation-related policy proposals in speeches by Trump and Clinton and in the two parties’ platforms that you begin to see how they diverge along ideological lines. Startups and technology giants alike depend on legions of highly educated foreigners working in the U.S. Immigration.

Education 40

Education Platform Training High Tech 40